| Literature DB >> 32404083 |
Hao Su1, Hongliang Wu2, Mandula Bao1, Shou Luo1, Xuewei Wang1, Chuanduo Zhao1, Qian Liu1, Xishan Wang1, Zhixiang Zhou3, Haitao Zhou4.
Abstract
BACKGROUND: To retrospectively evaluate the feasibility and safety of intraoperative assessment of bowel perfusion in totally laparoscopic surgery for colon cancer using indocyanine green fluorescence imaging (IGFI).Entities:
Keywords: Anastomotic leak; Bowel perfusion; Fluorescence imaging; Indocyanine green; Totally laparoscopy
Year: 2020 PMID: 32404083 PMCID: PMC7218821 DOI: 10.1186/s12893-020-00745-4
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1The surgical procedures of overlapped delta-shaped anastomosis using IGFI. a the perfusion of the bowel was assessed; b further “re-resection” up to a “fluorescent” portion; c the colon is transected within an area of well- perfused tissue; d the two broken ends of the intestines are joined; e the enterocolotomy is closed; and f the perfusion of anastomosis was assessed
Clinical characteristics of patients
| IGFI group ( | Control group ( | ||
|---|---|---|---|
| Gender, | 0.514 | ||
| Male | 48 (57.1) | 55 (52.4) | |
| Female | 36 (42.9) | 50 (47.6) | |
| Age, yr, mean ± SD | 59.1 ± 11.1 | 60.2 ± 9.8 | 0.478 |
| BMI, kg/m2, mean ± SD | 24.6 ± 3.4 | 23.8 ± 2.7 | 0.066 |
| ASA score, | 0.279 | ||
| 1 | 28 (33.3) | 45 (42.9) | |
| 2 | 50 (59.5) | 50 (47.6) | |
| 3 | 6 (7.1) | 10 (9.5) | |
| 4 | 0 | 0 | |
| Previous abdominal operation, | 0.083 | ||
| Yes | 17 (20.0) | 33 (31.4) | |
| No | 67 (80.0) | 72 (68.6) | |
| Preoperative neoadjuvant therapy, | |||
| NACT | 14 (16.7) | 30 (28.6) | 0.054 |
| No | 70 (83.3) | 75 (71.4) | |
| Tumor location, | 0.761 | ||
| Ileocecal junction | 20 (23.8) | 25 (23.8) | |
| Ascending colon | 25 (29.8) | 28 (26.7) | |
| Hepatic flexure | 9 (10.7) | 18 (17.1) | |
| Transverse colon | 12 (14.3) | 10 (9.5) | |
| Splenic flexure | 5 (5.9) | 6 (5.7) | |
| Descending colon | 8 (9.5) | 8 (7.6) | |
| High sigmoid colon | 5 (5.9) | 10 (9.5) | |
Surgical and pathological outcomes of patients
| IGFI group ( | Control group ( | ||
|---|---|---|---|
| Operation time, min, mean ± SD | 125.8 ± 34.9 | 136.6 ± 35.9 | 0.037 |
| Intraoperative blood loss, ml, mean ± SD | 45.7 ± 41.7 | 58.7 ± 53.7 | 0.062 |
| Surgical Procedure, | 0.747 | ||
| Right colectomy | 55 (65.5) | 72 (68.6) | |
| Transverse colectomy | 10 (11.9) | 9 (8.6) | |
| Left colectomy | 19 (22.6) | 24 (22.9) | |
| Removal method of the specimen, | 0.285 | ||
| Natural orifice | 5 (6.0) | 8 (7.6) | |
| Abdominal scar | 15 (17.9) | 28 (26.7) | |
| Pfannenstiel incision | 64 (76.2) | 69 (65.7) | |
| The length of tumor, cm, mean ± SD | 3.8 ± 1.5 | 3.6 ± 1.8 | 0.446 |
| Proximal resection margin, cm, mean ± SD | 11.1 ± 3.7 | 10.2 ± 2.9 | 0.088 |
| Distal resection margin, cm, mean ± SD | 9.7 ± 3.2 | 9.2 ± 1.9 | 0.190 |
| Number of lymph nodes retrieved, mean ± SD | 23.1 ± 9.4 | 21.8 ± 8.5 | 0.307 |
| pTNM stage, | 0.555 | ||
| I | 9 (10.7) | 15 (14.3) | |
| II | 32 (38.1) | 44 (41.9) | |
| III | 43 (51.2) | 46 (43.8) |
Postoperative recovery and complications
| IFGI group ( | Control group ( | ||
|---|---|---|---|
| Postoperative hospitalization, days, mean ± SD | 5.7 ± 1.4 | 6.0 ± 1.5 | 0.139 |
| Hospitalization cost, USD, mean ± SD | 9661.9 ± 987.7 | 9520.0 ± 854.4 | 0.291 |
| Postoperative complications, | 10 (11.9) | 13 (12.4) | 0.921 |
| Anastomotic leak | 0 | 0 | |
| Anastomotic stenosis | 0 | 0 | |
| Anastomotic bleeding | 1 (1.2) | 1 (1.0) | |
| Urinary tract infection | 1 (1.2) | 2 (1.9) | |
| Urinary retention | 1 (1.2) | 1 (1.0) | |
| Bowel obstruction | 1 (1.2) | 1 (1.0) | |
| Incisional infection | 6 (7.1) | 8 (7.6) | |
| ICG allergy | 0 | 0 | |
| Reoperation, | 0 | 0 | – |
| Readmission, | 0 | 0 | – |
| Mortality, | 0 | 0 | – |